15 February 2021 Priya Vaidya 860 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) byPriya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias05. Rules and Regulations10. Report Writing Related articles A Day in the Life of an Accountancy Expert Witness Kohler Mira Limited v Norcros Group (Holdings) Limited [2024] EWHC 3247 (Ch) Medical reporting agency at work Podcast Episode 9: Becoming an Expert Witness A mother's malign influence on her children Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.